Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP.
Aminoglycoside antibiotics such as streptomycin and tobramycin must traverse the bacterial cytoplasmic membrane prior to initiating lethal effects. Previous data on Escherichia coli, Staphylococcus aureus, and Bacillus subtilis have demonstrated that transport of aminoglycosides is regulated by delta psi, the electrical component of the proton motive force. However, several laboratories have observed that growth of bacterial cells can occur in the apparent absence of delta psi, and we wished to confirm these studies with E. coli and further investigate whether transport of aminoglycosides could occur in the absence of a membrane potential. Treatment of acrA strain CL2 with the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) dissipated delta psi, decreased intracellular ATP levels, and resulted in cessation of growth; after a variable period of time (3 to 7 h), growth resumed, ultimately achieving growth rates comparable to those of untreated cells. Absence of delta psi in these cells was confirmed by absence of [3H]tetraphenyl phosphonium+ uptake as measured by membrane filtration, lack of flagellar motion, and inability of these cells to transport proline (but not methionine). Regrowth was associated with restoration of normal intracellular ATP as measured by luciferin-luciferase bioluminescence assay. Unlike unacclimatized CL2 cells treated with CCCP, these cells transported [3H]tobramycin similarly to untreated cells; aminoglycoside-induced killing was seen in association with transport. These studies suggest that under certain circumstances aminoglycoside transport can be driven by ATP (or other high-energy activated phosphate donors) alone, in the absence of a measurable delta psi. delta uncBC mutants of CL2 incapable of interconverting delta psi and ATP were treated with CCCP, resulting in dissipation of delta psi but no alteration in ATP content. Despite maintenance of normal ATP, there was no transport of [3H] bramycin, confirming that under normal growth conditions ATP has no role in the transport of aminoglycosides.
Fraimow
H S
HS
Department of Medicine, Montefiore Hospital and Medical Center, Bronx, New York.
Greenman
J B
JB
Leviton
I M
IM
Dougherty
T J
TJ
Miller
M H
MH
D000255:Adenosine Triphosphate / Q000502:physiology*; D001149:Arsenates / Q000494:pharmacology; D001693:Biological Transport, Active / Q000502:physiology; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement; D002470:Cell Survival / Q000187:drug effects; D004926:Escherichia coli / Q000378:metabolism*; D008564:Membrane Potentials; D008715:Methionine / Q000378:metabolism; D008858:Microscopy, Phase-Contrast; D009861:Onium Compounds / Q000032:analysis; D009943:Organophosphorus Compounds / Q000032:analysis; D011392:Proline / Q000378:metabolism; D014031:Tobramycin / Q000493:pharmacokinetics*
D001149:Arsenates; D009861:Onium Compounds; D009943:Organophosphorus Compounds; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D000255:Adenosine Triphosphate; D011392:Proline; D008715:Methionine; C025657:arsenic acid; C013289:tetraphenylphosphonium; D014031:Tobramycin